Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 21757117)

1.

A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.

Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE.

J Am Coll Cardiol. 2011 Jul 19;58(4):395-401. doi: 10.1016/j.jacc.2011.03.031.

3.

Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.

Roldán V, Marín F, Fernández H, Manzano-Fernandez S, Gallego P, Valdés M, Vicente V, Lip GY.

Chest. 2013 Jan;143(1):179-84.

PMID:
22722228
4.

Development of a contemporary bleeding risk model for elderly warfarin recipients.

Shireman TI, Mahnken JD, Howard PA, Kresowik TF, Hou Q, Ellerbeck EF.

Chest. 2006 Nov;130(5):1390-6.

PMID:
17099015
6.

Age and the risk of warfarin-associated hemorrhage: the anticoagulation and risk factors in atrial fibrillation study.

Fang MC, Go AS, Hylek EM, Chang Y, Henault LE, Jensvold NG, Singer DE.

J Am Geriatr Soc. 2006 Aug;54(8):1231-6.

7.

Development of a novel composite stroke and bleeding risk score in patients with atrial fibrillation: the AMADEUS Study.

Lip GY, Lane DA, Buller H, Apostolakis S.

Chest. 2013 Dec;144(6):1839-47. doi: 10.1378/chest.13-1635.

PMID:
24009027
8.

The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.

Barnes GD, Gu X, Haymart B, Kline-Rogers E, Almany S, Kozlowski J, Besley D, Krol GD, Froehlich JB, Kaatz S.

Thromb Res. 2014 Aug;134(2):294-9. doi: 10.1016/j.thromres.2014.05.034. Epub 2014 Jun 2.

PMID:
24929840
9.

Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.

Oldgren J, Alings M, Darius H, Diener HC, Eikelboom J, Ezekowitz MD, Kamensky G, Reilly PA, Yang S, Yusuf S, Wallentin L, Connolly SJ; RE-LY Investigators.

Ann Intern Med. 2011 Nov 15;155(10):660-7, W204. doi: 10.7326/0003-4819-155-10-201111150-00004.

PMID:
22084332
10.
12.

Comparison of frequency and outcome of major gastrointestinal hemorrhage in patients with atrial fibrillation on versus not receiving warfarin therapy (from the ATRIA and ATRIA-CVRN cohorts).

Ashburner JM, Go AS, Reynolds K, Chang Y, Fang MC, Fredman L, Applebaum KM, Singer DE.

Am J Cardiol. 2015 Jan 1;115(1):40-6. doi: 10.1016/j.amjcard.2014.10.006. Epub 2014 Oct 12.

PMID:
25456871
13.

A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score.

Singer DE, Chang Y, Borowsky LH, Fang MC, Pomernacki NK, Udaltsova N, Reynolds K, Go AS.

J Am Heart Assoc. 2013 Jun 21;2(3):e000250. doi: 10.1161/JAHA.113.000250.

14.

Rates of hemorrhage during warfarin therapy for atrial fibrillation.

Gomes T, Mamdani MM, Holbrook AM, Paterson JM, Hellings C, Juurlink DN.

CMAJ. 2013 Feb 5;185(2):E121-7. doi: 10.1503/cmaj.121218. Epub 2012 Nov 26.

15.

Prevalence and predictors of warfarin use in patients with atrial fibrillation at low or intermediate risk and relation to thromboembolic events.

Chae SH, Froehlich J, Morady F, Oral H.

Clin Cardiol. 2011 Oct;34(10):640-4. doi: 10.1002/clc.20967.

PMID:
21994084
16.

Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes.

Hylek EM, Held C, Alexander JH, Lopes RD, De Caterina R, Wojdyla DM, Huber K, Jansky P, Steg PG, Hanna M, Thomas L, Wallentin L, Granger CB.

J Am Coll Cardiol. 2014 May 27;63(20):2141-7. doi: 10.1016/j.jacc.2014.02.549. Epub 2014 Mar 19.

PMID:
24657685
17.

Anticoagulation therapy for patients with non-valvular atrial fibrillation: comparison of decision analytic model recommendations and real-world warfarin prescription use.

Casciano JP, Singer DE, Kwong WJ, Fox ES, Martin BC.

Am J Cardiovasc Drugs. 2012 Oct 1;12(5):313-23. doi: 10.2165/11634150-000000000-00000.

PMID:
22920047
18.

Bleeding complications associated with warfarin treatment in ischemic stroke patients with atrial fibrillation: a population-based cohort study.

Seet RC, Rabinstein AA, Christianson TJ, Petty GW, Brown RD Jr.

J Stroke Cerebrovasc Dis. 2013 May;22(4):561-9. doi: 10.1016/j.jstrokecerebrovasdis.2013.01.019. Epub 2013 Mar 15.

19.

Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF).

Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, Radford MJ.

Am Heart J. 2006 Mar;151(3):713-9.

PMID:
16504638
20.

The net clinical benefit of warfarin anticoagulation in atrial fibrillation.

Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS.

Ann Intern Med. 2009 Sep 1;151(5):297-305.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk